Gene expression analysis comparing immune infiltration in the mRCC treatment-naïve cohort and mRCC cohort from the daratumumab study (prior to treatment) and showing significant reduction across immune cell subtypes in heavily pretreated patients. Tx, treatment.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: